Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

M. Ruella, S. S. Kenderian, O. Shestova, M. Klichinsky, J. J. Melenhorst, M. A. Wasik, S. F. Lacey, C. H. June, S. Gill

Research output: Contribution to journal › Letter › peer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms'. Together they form a unique fingerprint.